ARCHIVES

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Sen. Specter Seeks NCI Explanation of Delay in P-4 Breast Cancer Prevention Trial.

May 25, 2007

House Committee on Appropriations approves $28.5 billion for NIH.

June 24, 2005

Detroit’s “Dr. Vee” Honored For 50 Years In Medicine.

November 9, 2001

Guest Editorial: As ACS Turns 100, Society President Calls For Tools To Finish the Fight Against Cancer

May 17, 2013

Crizotinib Eliminated Tumors In 7 of 8 Children with ALCL

May 25, 2012

ACCC Comments On DRGs to Be Review By PROPAC

September 6, 1985